{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:39:47Z","timestamp":1780922387738,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T00:00:00Z","timestamp":1519257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10067-018-4037-y","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T17:34:00Z","timestamp":1519320840000},"page":"1053-1058","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Ischemic heart disease and ankylosing spondylitis\u2014assessing the role of inflammation"],"prefix":"10.1007","volume":"37","author":[{"given":"Michal","family":"Vinker Shuster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shmuel","family":"Tiosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Comaneshter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Amital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,22]]},"reference":[{"issue":"suppl 3","key":"4037_CR1","doi-asserted-by":"publisher","first-page":"iii8","DOI":"10.1136\/ard.61.suppl_3.iii8","volume":"61","author":"J Sieper","year":"2002","unstructured":"Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61(suppl 3):iii8\u2013iii18","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4037_CR2","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ejim.2011.06.006","volume":"22","author":"A Maghraoui El","year":"2011","unstructured":"El Maghraoui A (2011) Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med 22(6):554\u2013560","journal-title":"Eur J Intern Med"},{"issue":"4","key":"4037_CR3","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","volume":"53","author":"LE Dean","year":"2014","unstructured":"Dean LE, Jones GT, MacDonald AG, Downham C, Sturrock RD, Macfarlane GJ (2014) Global prevalence of ankylosing spondylitis. Rheumatology 53(4):650\u2013657","journal-title":"Rheumatology"},{"key":"4037_CR4","doi-asserted-by":"publisher","unstructured":"Elewaut D, Matucci-Cerinic M (2009) Treatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practice. Rheumatology. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kep146","DOI":"10.1093\/rheumatology\/kep146"},{"issue":"6","key":"4037_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.14740\/jocmr2488w","volume":"8","author":"Y Ozkan","year":"2016","unstructured":"Ozkan Y (2016) Cardiac involvement in ankylosing spondylitis. J Clin Med Res 8(6):427\u2013430","journal-title":"J Clin Med Res"},{"key":"4037_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/728471","volume":"2011","author":"M Momeni","year":"2011","unstructured":"Momeni M, Taylor N, Tehrani M (2011) Cardiopulmonary manifestations of ankylosing spondylitis. Int J Rheumatol 2011:1\u20136","journal-title":"Int J Rheumatol"},{"issue":"4","key":"4037_CR7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/acr.20408","volume":"63","author":"A Bremander","year":"2011","unstructured":"Bremander A, Petersson IF, Bergman S, Englund M (2011) Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res 63(4):550\u2013556. \n                    https:\/\/doi.org\/10.1002\/acr.20408","journal-title":"Arthritis Care Res"},{"issue":"11","key":"4037_CR8","first-page":"2167","volume":"33","author":"C Han","year":"2006","unstructured":"Han C, Robinson DW, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33(11):2167\u20132172","journal-title":"J Rheumatol"},{"issue":"5","key":"4037_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11926-012-0270-6","volume":"14","author":"MT Nurmohamed","year":"2012","unstructured":"Nurmohamed MT, Van der Horst-Bruinsma I, Maksymowych WP (2012) Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights. Curr Rheumatol Rep 14(5):415\u2013421. \n                    https:\/\/doi.org\/10.1007\/s11926-012-0270-6","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"4037_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/acr.20364","volume":"63","author":"S Mathieu","year":"2011","unstructured":"Mathieu S, Gossec L, Dougados M, Soubrier M (2011) Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res 63(4):557\u2013563. \n                    https:\/\/doi.org\/10.1002\/acr.20364","journal-title":"Arthritis Care Res"},{"issue":"2","key":"4037_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3109\/03009742.2013.822097","volume":"43","author":"C-H Chou","year":"2014","unstructured":"Chou C-H, Lin M-C, Peng C-L, Wu YC, Sung FC, Kao CH, Liu SH (2014) A nationwide population-based retrospective cohort study: increased risk of acute coronary syndrome in patients with ankylosing spondylitis. Scand J Rheumatol 43(2):132\u2013136. \n                    https:\/\/doi.org\/10.3109\/03009742.2013.822097","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"4037_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jbspin.2010.05.001","volume":"77","author":"S Mathieu","year":"2010","unstructured":"Mathieu S, Motreff P, Soubrier M (2010) Spondyloarthropathies: an independent cardiovascular risk factor? Joint Bone Spine 77(6):542\u2013545","journal-title":"Joint Bone Spine"},{"issue":"5","key":"4037_CR13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s10067-006-0380-5","volume":"26","author":"D Malesci","year":"2007","unstructured":"Malesci D, Niglio A, Mennillo GA, Buono R, Valentini G, La Montagna G (2007) High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol 26(5):710\u2013714","journal-title":"Clin Rheumatol"},{"issue":"2","key":"4037_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1042\/CS20040326","volume":"109","author":"H Divecha","year":"2005","unstructured":"Divecha H, Sattar N, Rumley A, Cherry L, Lowe GDO, Sturrock R (2005) Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci 109(2):171\u2013176","journal-title":"Clin Sci"},{"key":"4037_CR15","doi-asserted-by":"crossref","unstructured":"Peters MJ, Van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34(3):585\u2013592","DOI":"10.1016\/j.semarthrit.2004.07.010"},{"issue":"5","key":"4037_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJMra1201534","volume":"369","author":"CJL Murray","year":"2013","unstructured":"Murray CJL, Lopez AD (2013) Measuring the global burden of disease. N Engl J Med 369(5):448\u2013457","journal-title":"N Engl J Med"},{"issue":"6","key":"4037_CR17","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/acr.22512","volume":"67","author":"KA Wright","year":"2015","unstructured":"Wright KA, Crowson CS, Michet CJ, Matteson EL (2015) Time trends in incidence, clinical features, and cardiovascular disease in ankylosing spondylitis over three decades: a population-based study. Arthritis Care Res 67(6):836\u2013841. \n                    https:\/\/doi.org\/10.1002\/acr.22512","journal-title":"Arthritis Care Res"},{"issue":"12","key":"4037_CR18","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1007\/s10067-016-3362-2","volume":"35","author":"N Ahmed","year":"2016","unstructured":"Ahmed N, Prior JA, Chen Y, Hayward R, Mallen CD, Hider SL (2016) Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study. Clin Rheumatol 35(12):3069\u20133073. \n                    https:\/\/doi.org\/10.1007\/s10067-016-3362-2","journal-title":"Clin Rheumatol"},{"issue":"2","key":"4037_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1136\/annrheumdis-2016-209315","volume":"76","author":"JK Eriksson","year":"2017","unstructured":"Eriksson JK, Jacobsson L, Bengtsson K, Askling J (2017) Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis? Ann Rheum Dis 76(2):364\u2013370. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2016-209315","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4037_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064155","volume":"8","author":"Y-P Huang","year":"2013","unstructured":"Huang Y-P, Wang Y-H, Pan S-L (2013) Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis\u2014a population-based longitudinal follow-up study. PLoS One 8(5):e64155. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0064155","journal-title":"PLoS One"},{"issue":"1","key":"4037_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/annrheumdis-2014-206147","volume":"75","author":"I Essers","year":"2016","unstructured":"Essers I, Stolwijk C, Boonen A, de Bruin ML, Bazelier MT, de Vries F, van Tubergen A (2016) Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Ann Rheum Dis 75(1):203\u2013209. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2014-206147","journal-title":"Ann Rheum Dis"},{"key":"4037_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00393-016-0092-4","volume":"76","author":"A Kucuk","year":"2016","unstructured":"Kucuk A, U\u011fur Uslu A, Icli A, Cure E, Arslan S, Turkmen K, Toker A, Kayrak M (June 2016) The LDL\/HDL ratio and atherosclerosis in ankylosing spondylitis. Z Rheumatol 76:58\u201363. \n                    https:\/\/doi.org\/10.1007\/s00393-016-0092-4","journal-title":"Z Rheumatol"},{"issue":"2","key":"4037_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.semarthrit.2012.02.008","volume":"42","author":"S Brophy","year":"2012","unstructured":"Brophy S, Cooksey R, Atkinson M, Zhou SM, Husain MJ, Macey S, Rahman MA, Siebert S (2012) No increased rate of acute myocardial infarction or stroke among patients with ankylosing spondylitis\u2014a retrospective cohort study using routine data. Semin Arthritis Rheum 42(2):140\u2013145. \n                    https:\/\/doi.org\/10.1016\/j.semarthrit.2012.02.008","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"4037_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jbspin.2013.03.019","volume":"81","author":"C Papagoras","year":"2014","unstructured":"Papagoras C, Markatseli TE, Saougou I, Alamanos Y, Zikou AK, Voulgari PV, Kiortsis DN, Drosos AA (2014) Cardiovascular risk profile in patients with spondyloarthritis. Joint Bone Spine 81(1):57\u201363. \n                    https:\/\/doi.org\/10.1016\/j.jbspin.2013.03.019","journal-title":"Joint Bone Spine"},{"issue":"21","key":"4037_CR25","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","volume":"112","author":"Y Shoenfeld","year":"2005","unstructured":"Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N, Jara LJ, Abu-Shakra M, Meroni PL, Sherer Y (2005) Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112(21):3337\u20133347","journal-title":"Circulation"},{"issue":"2","key":"4037_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jaut.2007.02.004","volume":"28","author":"BH Hahn","year":"2007","unstructured":"Hahn BH, Grossman J, Chen W, McMahon M (2007) The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 28(2):69\u201375","journal-title":"J Autoimmun"},{"issue":"7","key":"4037_CR27","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/art.11078","volume":"48","author":"I Rinc\u00f3n Del","year":"2003","unstructured":"Del Rinc\u00f3n I, Williams K, Stern MP, Freeman GL, O\u2019leary DH, Escalante A (2003) Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 48(7):1833\u20131840","journal-title":"Arthritis Rheum"},{"issue":"25","key":"4037_CR28","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1056\/NEJMoa035471","volume":"349","author":"MJ Roman","year":"2003","unstructured":"Roman MJ, Shanker B-A, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349(25):2399\u20132406","journal-title":"N Engl J Med"},{"issue":"10","key":"4037_CR29","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.06.010","volume":"121","author":"JE Salmon","year":"2008","unstructured":"Salmon JE, Roman MJ (2008) Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 121(10):S3\u2013S8","journal-title":"Am J Med"},{"issue":"3","key":"4037_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/rheumatology\/kei145","volume":"45","author":"I Sari","year":"2006","unstructured":"Sari I, Okan T, Akar S, Cece H, Altay C, Secil M, Birlik M, Onen F, Akkoc N (2006) Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology 45(3):283\u2013286","journal-title":"Rheumatology"},{"issue":"1","key":"4037_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3899\/jrheum.090667","volume":"37","author":"MJL Peters","year":"2010","unstructured":"Peters MJL, Smulders Y, Serne E, Dijkmans B, van der Horst-Bruinsma IE, Nurmohamed MT (2010) Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis. J Rheumatol 37(1):161\u2013166","journal-title":"J Rheumatol"},{"issue":"3","key":"4037_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/ard.2007.086777","volume":"68","author":"IC Eijk Van","year":"2009","unstructured":"Van Eijk IC, Peters MJL, Serne EH et al (2009) Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor \u03b1 blockade. Ann Rheum Dis 68(3):362\u2013366","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4037_CR33","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","volume":"74","author":"C Roubille","year":"2015","unstructured":"Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B (2015) The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 74(3):480\u2013489. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2014-206624","journal-title":"Ann Rheum Dis"},{"issue":"78","key":"4037_CR34","first-page":"24","volume":"33","author":"DO Clegg","year":"2006","unstructured":"Clegg DO (2006) Treatment of ankylosing spondylitis. J Rheumatol Suppl 33(78):24","journal-title":"J Rheumatol Suppl"},{"issue":"26","key":"4037_CR35","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1056\/NEJMra1406182","volume":"374","author":"JD Taurog","year":"2016","unstructured":"Taurog JD, Chhabra A, Colbert RA (2016) Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 374(26):2563\u20132574","journal-title":"N Engl J Med"},{"issue":"9","key":"4037_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001098","volume":"8","author":"P McGettigan","year":"2011","unstructured":"McGettigan P, Henry D (2011) Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med 8(9):e1001098","journal-title":"PLoS Med"},{"issue":"1","key":"4037_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/ard.2005.036269","volume":"65","author":"WW Bolten","year":"2006","unstructured":"Bolten WW (2006) Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs. Ann Rheum Dis 65(1):7\u201313","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4037_CR38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"MJL Peters","year":"2010","unstructured":"Peters MJL, Symmons DPM, McCarey D, Dijkmans BAC, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325\u2013331","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4037_CR39","doi-asserted-by":"publisher","first-page":"R141","DOI":"10.1186\/ar3874","volume":"14","author":"I Stagakis","year":"2012","unstructured":"Stagakis I, Bertsias G, Karvounaris S, Kavousanaki M, Virla D, Raptopoulou A, Kardassis D, Boumpas DT, Sidiropoulos PI (2012) Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance. Arthritis Res Ther 14(3):R141","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"4037_CR40","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1136\/annrheumdis-2011-201148","volume":"71","author":"CI Da\u00efen","year":"2012","unstructured":"Da\u00efen CI, Duny Y, Barnetche T, Daur\u00e8s J-P, Combe B, Morel J (2012) Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis. Ann Rheum Dis 71(6):862\u2013868","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4037_CR41","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/rheumatology\/keq316","volume":"50","author":"SL Westlake","year":"2011","unstructured":"Westlake SL, Colebatch AN, Baird J, Curzen N, Kiely P, Quinn M, Choy E, Ostor AJK, Edwards CJ (2011) Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology 50(3):518\u2013531","journal-title":"Rheumatology"},{"issue":"4","key":"4037_CR42","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/acr.20371","volume":"63","author":"C Barnabe","year":"2011","unstructured":"Barnabe C, Martin B, Ghali WA (2011) Systematic review and meta-analysis: anti\u2013tumor necrosis factor \u03b1 therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res 63(4):522\u2013529","journal-title":"Arthritis Care Res"},{"issue":"5","key":"4037_CR43","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1177\/1759720X16664306","volume":"8","author":"A Tournadre","year":"2016","unstructured":"Tournadre A, Mathieu S, Soubrier M (2016) Managing cardiovascular risk in patients with inflammatory arthritis: practical considerations. Ther Adv Musculoskelet Dis 8(5):180\u2013191. \n                    https:\/\/doi.org\/10.1177\/1759720X16664306","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"3\u20134","key":"4037_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000481992","volume":"49","author":"S Tiosano","year":"2017","unstructured":"Tiosano S, Yavne Y, Gendelman O, Watad A, Comaneshter D, Shoenfeld Y, Cohen AD, Amital D (2017) Stroke among rheumatoid arthritis patients: does age matter a real-life study. Neuroepidemiology 49(3\u20134):99\u2013105. \n                    https:\/\/doi.org\/10.1159\/000481992","journal-title":"Neuroepidemiology"},{"key":"4037_CR45","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/eci.12757","volume":"47","author":"M Versini","year":"2017","unstructured":"Versini M, Tiosano S, Comaneshter D, Shoenfeld Y, Cohen AD, Amital H (April 2017) Smoking and obesity in systemic lupus erythematosus: a cross-sectional study. Eur J Clin Investig 47:422\u2013427. \n                    https:\/\/doi.org\/10.1111\/eci.12757","journal-title":"Eur J Clin Investig"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4037-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4037-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4037-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T19:36:27Z","timestamp":1550777787000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4037-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,22]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["4037"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4037-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,22]]},"assertion":[{"value":"23 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of CHS, located in the Soroka Medical Center, Beer-Sheva, Israel.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Prof. Arnon Cohen: Relationships relevant to this manuscript: Prof. Arnon Cohen received research grants from Janssen, Novartis, AbbVie and Sanofi. Other relationships: In the last 3\u00a0years, Prof. Arnon Cohen served as a consultant, advisor or speaker to AbbVie; Amgen; Boehringer Ingelheim; Dexcel pharma; Janssen; Kamedis; Lilly; Neopharm; Novartis; Perrigo; Pfizer, Rafa, Sanofi, Sirbal; Taro. All other authors declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}